Reporte zur Charge U1D852M

Symptomtext

a new pediatric nurse administered IMOVAX subcutaneously instead of intramuscularly with no reported adverse event; Initial information received on 03-Jun-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 11 years old male patient and it was reported that a new pediatric nurse administered imovax subcutaneously instead of intramuscularly with no reported adverse event while receiving vaccine RABIES (HDC) VACCINE [IMOVAX RABIES]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 02-JUN-2022 , a new pediatric nurse administered imovax subcutaneously instead of intramuscularly with no reported adverse event (incorrect route of product administration) (latency: same day) following the administration of RABIES (HDC) VACCINE. The patient received a 1 ml dose of suspect RABIES (HDC) VACCINE, once, ( lot : U1D852M ; expiry date: 31-Aug-2023) via subcutaneous route in unknown administration site for immunization. Action taken: not applicable. Outcome: unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.